During a panel at MedCity News’ INVEST conference, venture capitalists shared some of their takes on today’s healthcare funding landscape — including their thoughts on AI and the industry’s slower investment pace.
Offering safe affordable family-forming programs for everyone, including vulnerable or under-served employee populations, represents an opportunity for employers to build a caring culture that also will benefit the bottom line.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
Inato recently raised $20 million in Series A2 funding for its tech platform, which enables access to inclusive clinical trials. The two-way platform brings exposure to community-based providers who often are overlooked by Big Pharma for clinical trial sites by allowing providers to apply for clinical trials in which they're interested.
About 21,000 Kaiser Permanente nurses in Northern California ratified a new four-year contract — one that includes provisions for a 22.5% wage increase, improved staffing and more. The contract's approval comes about two weeks after Kaiser reached an agreement with California Nurses Association to avert what would have been the biggest private sector nurses strike in American history.
Third Culture Capital (3CC) is a venture capital firm founded with the mission to foster more equity and diversity in health technology innovation. 3CC Founder and Managing Partner said the firm is intentional about connecting to the “unique lived experiences” of the founders it invests in, as this approach ensures that it is not just checking its diversity boxes.
Taking steps to eliminate health disparities among people of color and ensuring diversity throughout the development cycle should be a strategic goal for all. Medical Affairs can be the change agents within their organizations to help with this push.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Artificial intelligence can help drug study teams solve operational, scientific and ethical challenges. For example, AI can be used to flag real-time trends emerging in drug trials that might otherwise not be obvious until the end of a study when all the data is analyzed.
Whether seeking to overcome ongoing hesitation of the Covid-19 vaccine or searching for moonshot cancer solutions, whatever the healthcare need demands, seeking results for diverse populations must be a priority.
Reaching out to and connecting with communities of color is a moral imperative. It’s a business imperative. For the healthcare system, it is no longer an option in an increasingly multicultural society.
Not only is the community at a higher risk of severe Covid-19 outcomes, but LGBTQ+ people are also suffering from mental health issues associated with social isolation.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
I am a venture capitalist in California and believe that the state's SB 826 bill that just passed requiring public companies headquartered in the state to have women on corporate boards will be a boon for shareholders. Here's why.